← Evidence map

ArticleTranslational andrology and urology2024

Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer.

Maria Rusan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38721296